HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report

Key Clinical Message HRAS mutations are frequent genetic alterations in epithelial‐myoepithelial carcinoma, and they may be useful as ancillary molecular tests and predictive molecular tests for targeted therapy with tipifarnib.

Bibliographic Details
Main Authors: Taisei Yasuda, Masami Osaki, Masahiko Sugitani
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.8099
_version_ 1827784294417825792
author Taisei Yasuda
Masami Osaki
Masahiko Sugitani
author_facet Taisei Yasuda
Masami Osaki
Masahiko Sugitani
author_sort Taisei Yasuda
collection DOAJ
description Key Clinical Message HRAS mutations are frequent genetic alterations in epithelial‐myoepithelial carcinoma, and they may be useful as ancillary molecular tests and predictive molecular tests for targeted therapy with tipifarnib.
first_indexed 2024-03-11T15:59:57Z
format Article
id doaj.art-7f9bc0e80562459088c9fe653ad3e4e3
institution Directory Open Access Journal
issn 2050-0904
language English
last_indexed 2024-03-11T15:59:57Z
publishDate 2023-10-01
publisher Wiley
record_format Article
series Clinical Case Reports
spelling doaj.art-7f9bc0e80562459088c9fe653ad3e4e32023-10-25T07:12:45ZengWileyClinical Case Reports2050-09042023-10-011110n/an/a10.1002/ccr3.8099HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case reportTaisei Yasuda0Masami Osaki1Masahiko Sugitani2Department of Otolaryngology‐Head and Neck Surgery Ageo Central General Hospital Saitama JapanDepartment of Otolaryngology‐Head and Neck Surgery Ageo Central General Hospital Saitama JapanDepartment of Pathology Ageo Central General Hospital Saitama JapanKey Clinical Message HRAS mutations are frequent genetic alterations in epithelial‐myoepithelial carcinoma, and they may be useful as ancillary molecular tests and predictive molecular tests for targeted therapy with tipifarnib.https://doi.org/10.1002/ccr3.8099epithelial‐myoepithelial carcinomaHRAS mutationsalivary gland carcinoma
spellingShingle Taisei Yasuda
Masami Osaki
Masahiko Sugitani
HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report
Clinical Case Reports
epithelial‐myoepithelial carcinoma
HRAS mutation
salivary gland carcinoma
title HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report
title_full HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report
title_fullStr HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report
title_full_unstemmed HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report
title_short HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report
title_sort hras mutation as a diagnostic molecular analysis for epithelial myoepithelial carcinoma of the parotid gland a case report
topic epithelial‐myoepithelial carcinoma
HRAS mutation
salivary gland carcinoma
url https://doi.org/10.1002/ccr3.8099
work_keys_str_mv AT taiseiyasuda hrasmutationasadiagnosticmolecularanalysisforepithelialmyoepithelialcarcinomaoftheparotidglandacasereport
AT masamiosaki hrasmutationasadiagnosticmolecularanalysisforepithelialmyoepithelialcarcinomaoftheparotidglandacasereport
AT masahikosugitani hrasmutationasadiagnosticmolecularanalysisforepithelialmyoepithelialcarcinomaoftheparotidglandacasereport